UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

EMT cells increase breast cancer metastasis via paracrine GLI activation in neighbouring tumour cells

Nature communications, 2017-06, Vol.8 (1), p.15773-15773, Article 15773

2017

Volltextzugriff (PDF)

Multicenter Phase II Study of Neoadjuvant Lapatinib and Trastuzumab With Hormonal Therapy and Without Chemotherapy in Patients With Human Epidermal Growth Factor Receptor 2–Overexpressing Breast Cancer: TBCRC 006

Journal of clinical oncology, 2013-05, Vol.31 (14), p.1726-1731

2013

Volltextzugriff (PDF)

Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features

Proceedings of the National Academy of Sciences - PNAS, 2009-08, Vol.106 (33), p.13820-13825

2009

Volltextzugriff (PDF)

Hippo Pathway Effector Yap Is an Ovarian Cancer Oncogene

Cancer research (Chicago, Ill.), 2010-11, Vol.70 (21), p.8517-8525

2010

Volltextzugriff (PDF)

FOXA1 overexpression mediates endocrine resistance by altering the ER transcriptome and IL-8 expression in ER-positive breast cancer

Proceedings of the National Academy of Sciences - PNAS, 2016-10, Vol.113 (43), p.E6600-E6609

2016

Volltextzugriff (PDF)

STAT3 Signaling Is Activated Preferentially in Tumor‐Initiating Cells in Claudin‐Low Models of Human Breast Cancer

Stem cells (Dayton, Ohio), 2014-10, Vol.32 (10), p.2571-2582

2014

Volltextzugriff (PDF)

Loss of Phosphatase and Tensin Homolog or Phosphoinositol-3 Kinase Activation and Response to Trastuzumab or Lapatinib in Human Epidermal Growth Factor Receptor 2–Overexpressing Locally Advanced Breast Cancers

Journal of clinical oncology, 2011-01, Vol.29 (2), p.166-173

2011

Volltextzugriff (PDF)

Phosphatase PTP4A3 Promotes Triple-Negative Breast Cancer Growth and Predicts Poor Patient Survival

Cancer research (Chicago, Ill.), 2016-04, Vol.76 (7), p.1942-1953

2016

Volltextzugriff (PDF)

Insulin-Like Growth Factor-I Activates Gene Transcription Programs Strongly Associated With Poor Breast Cancer Prognosis

Journal of clinical oncology, 2008-09, Vol.26 (25), p.4078-4085

2008

Volltextzugriff (PDF)

Modernizing Eligibility Criteria for Molecularly Driven Trials

Journal of clinical oncology, 2015-09, Vol.33 (25), p.2815-2820

2015

Volltextzugriff (PDF)

The novel phosphatase NUDT5 is a critical regulator of triple-negative breast cancer growth

Breast cancer research : BCR, 2024-02, Vol.26 (1), p.23-23, Article 23

2024

Volltextzugriff (PDF)

Correction: The novel phosphatase NUDT5 is a critical regulator of triple-negative breast cancer growth

Breast cancer research : BCR, 2024-03, Vol.26 (1), p.53-53, Article 53

2024

Volltextzugriff (PDF)

Proteomic and transcriptomic profiling reveals a link between the PI3K pathway and lower estrogen-receptor (ER) levels and activity in ER+ breast cancer

Breast cancer research : BCR, 2010-06, Vol.12 (3), p.R40-R40, Article R40

2010

Volltextzugriff (PDF)

Assessment of the learning curve for pancreaticoduodenectomy

The American journal of surgery, 2012-06, Vol.203 (6), p.684-690

2012

Volltextzugriff (PDF)

The Signaling Pathways Project, an integrated 'omics knowledgebase for mammalian cellular signaling pathways

Scientific data, 2019-10, Vol.6 (1), p.252-21, Article 252

2019

Volltextzugriff (PDF)

GATA2 facilitates steroid receptor coactivator recruitment to the androgen receptor complex

Proceedings of the National Academy of Sciences - PNAS, 2014-12, Vol.111 (51), p.18261-18266

2014

Volltextzugriff (PDF)

The SOX11 transcription factor is a critical regulator of basal-like breast cancer growth, invasion, and basal-like gene expression

Oncotarget, 2016-03, Vol.7 (11), p.13106-13121

2016

Volltextzugriff (PDF)

Making Sense of Clinical Trial Data: Is Inverse Probability of Censoring Weighted Analysis the Answer to Crossover Bias?

Journal of clinical oncology, 2012-02, Vol.30 (4), p.453-458

2012

Volltextzugriff (PDF)

Social Networkers' Attitudes Toward Direct-to-Consumer Personal Genome Testing

American journal of bioethics, 2009-01, Vol.9 (6-7), p.3-10

2009

Volltextzugriff (PDF)

HER2 Signaling Drives DNA Anabolism and Proliferation through SRC-3 Phosphorylation and E2F1-Regulated Genes

Cancer research (Chicago, Ill.), 2016-03, Vol.76 (6), p.1463-1475

2016

Volltextzugriff (PDF)

The HOXB13:IL17BR Expression Index Is a Prognostic Factor in Early-Stage Breast Cancer

Journal of clinical oncology, 2006-10, Vol.24 (28), p.4611-4619

2006

Volltextzugriff (PDF)

Bayesian Optimal Interval Design: A Simple and Well-Performing Design for Phase I Oncology Trials

Clinical cancer research, 2016-09, Vol.22 (17), p.4291-4301

2016

Volltextzugriff (PDF)

A fully Bayesian latent variable model for integrative clustering analysis of multi-type omics data

Biostatistics (Oxford, England), 2018-01, Vol.19 (1), p.71-86

2018

Volltextzugriff (PDF)

Model-Assisted Designs for Early-Phase Clinical Trials: Simplicity Meets Superiority

JCO precision oncology, 2019 (3), p.1-12

2019

Volltextzugriff (PDF)

1 – 25 von 299

Suche als RSS-Feed

Aktive Filter

KollektionJSTOR Complete Journals

ThemaMice

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(292)
Mit Volltextzugriff
(275)

Publikationsform

Artikel
(298)
Tagungsberichte
(1)

Sprache

Englisch
(299)
Japanisch
(48)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

EMT cells increase breast cancer metastasis via paracrine GLI activation in neighbouring tumour cells

Multicenter Phase II Study of Neoadjuvant Lapatinib and Trastuzumab With Hormonal Therapy and Without Chemotherapy in Patients With Human Epidermal Growth Factor Receptor 2–Overexpressing Breast Cancer: TBCRC 006

Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features

Hippo Pathway Effector Yap Is an Ovarian Cancer Oncogene

FOXA1 overexpression mediates endocrine resistance by altering the ER transcriptome and IL-8 expression in ER-positive breast cancer

STAT3 Signaling Is Activated Preferentially in Tumor‐Initiating Cells in Claudin‐Low Models of Human Breast Cancer

Loss of Phosphatase and Tensin Homolog or Phosphoinositol-3 Kinase Activation and Response to Trastuzumab or Lapatinib in Human Epidermal Growth Factor Receptor 2–Overexpressing Locally Advanced Breast Cancers

Phosphatase PTP4A3 Promotes Triple-Negative Breast Cancer Growth and Predicts Poor Patient Survival

Insulin-Like Growth Factor-I Activates Gene Transcription Programs Strongly Associated With Poor Breast Cancer Prognosis

Modernizing Eligibility Criteria for Molecularly Driven Trials

Activation of Multiple Proto-oncogenic Tyrosine Kinases in Breast Cancer via Loss of the PTPN12 Phosphatase

The novel phosphatase NUDT5 is a critical regulator of triple-negative breast cancer growth

Correction: The novel phosphatase NUDT5 is a critical regulator of triple-negative breast cancer growth

Proteomic and transcriptomic profiling reveals a link between the PI3K pathway and lower estrogen-receptor (ER) levels and activity in ER+ breast cancer

Assessment of the learning curve for pancreaticoduodenectomy

The Signaling Pathways Project, an integrated 'omics knowledgebase for mammalian cellular signaling pathways

GATA2 facilitates steroid receptor coactivator recruitment to the androgen receptor complex

The SOX11 transcription factor is a critical regulator of basal-like breast cancer growth, invasion, and basal-like gene expression

Making Sense of Clinical Trial Data: Is Inverse Probability of Censoring Weighted Analysis the Answer to Crossover Bias?

Social Networkers' Attitudes Toward Direct-to-Consumer Personal Genome Testing

HER2 Signaling Drives DNA Anabolism and Proliferation through SRC-3 Phosphorylation and E2F1-Regulated Genes

The HOXB13:IL17BR Expression Index Is a Prognostic Factor in Early-Stage Breast Cancer

Bayesian Optimal Interval Design: A Simple and Well-Performing Design for Phase I Oncology Trials

A fully Bayesian latent variable model for integrative clustering analysis of multi-type omics data

Model-Assisted Designs for Early-Phase Clinical Trials: Simplicity Meets Superiority

Aktive Filter

Suchergebnisse filtern